/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Jian Xu

National Center for Clinical Laboratories(CN)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

24

Papers

654

Citations

13

h-index

17

i10-index

Jian Xu is an academic researcher from National Center for Clinical Laboratories. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Immune cells in cancer. The author has an h-index of 13, co-authored 21 publications.

ORCID: 0000-0001-8132-8988

Research Topics

Cancer Immunotherapy and Biomarkers Pancreatic and Hepatic Oncology Research Immune cells in cancer Autophagy in Disease and Therapy Ferroptosis and cancer prognosis

Papers by this author

works

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

2022 · Journal for ImmunoTherapy of Cancer · 73 citations

https://doi.org/10.1136/jitc-2021-003982

Xiaozhen Zhang Mengyi Lao Jian Xu Yi Duan

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix

2023 · Oncogene · 45 citations

https://doi.org/10.1038/s41388-023-02711-9

Yi Duan Xiaozhen Zhang Honggang Ying Jian Xu

Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells

2021 · Oncogene · 22 citations

https://doi.org/10.1038/s41388-021-01763-z

Mengyi Lao Xiaozhen Zhang Tao Ma Jian Xu

Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy

2020 · npj Precision Oncology · 13 citations

https://doi.org/10.1038/s41698-020-00136-1

Xing Huang Tianyu Tang Gang Zhang Zhengtao Hong

[Effect of SMARCA4 mutations on the outcomes of patients with advanced EGFR mutant lung adenocarcinoma].

2025 · PubMed · 0 citations

https://doi.org/10.3760/cma.j.cn112137-20240904-02043

Xiaowen Liang Yangqian Jiang Xianfeng Liu Jian Xu

Research topics

topics

Cancer Immunotherapy and Biomarkers

Pancreatic and Hepatic Oncology Research

Immune cells in cancer

Autophagy in Disease and Therapy

Ferroptosis and cancer prognosis

Chat about Author

Papers

Chat

Click to start Chat